The length of hospital stays and death among patients with chronic obstructive pulmonary disease are tied to various socioeconomic and clinical factors.

SNY misses Q2 earnings and sales estimates but lifts 2025 sales outlook on strong Dupixent and vaccine momentum.

Modern medicine is largely reactive—treating illness only after symptoms emerge. But a new study from the Research Institute ...

European regulators have given their backing to a new eco-friendly inhaler that could help curb health care’s climate impact.

Baron Funds, an investment management company, released its “Baron Health Care Fund” second-quarter 2025 investor letter. A ...

Your sleep tracker might be more honest than you are. A massive study reveals poor sleep rhythm—not sleep duration—is what ...

As the NHS faces ever-increasing demand, persistent staffing shortages, and an expanding backlog of care, all eyes are on ...

In the largest study of its kind, researchers linked irregular sleep patterns to elevated risk for 172 diseases.

Hengrui Pharma has signed an agreement with GSK for the development of up to 12 innovative medicines across several therapeutic areas.

The world's first wearable-powered system predicts acute inflammation with 90 per cent sensitivityModern medicine is largely ...

This groundbreaking work, conducted at The Institute’s Centre for Innovative Medicine, led to the creation of Sensifai Health ...

For long, Indians have kept cars for decades until they could run no more. As pollution concerns rise, the government is ...